1. Peng Guo , Wen-Jing Zhang , Teng-Hong Lian , Wei-Jiao Zhang , Ming-Yue He , Ya-Nan Zhang , Yue Huang , Du-Yu Ding , Hui-Ying Guan , Jing-Hui Li , Dan-Ning Li , Dong-Mei Luo , Wei-Jia Zhang , Hao Yue , Xiao-Min Wang , Wei Zhang*.Alzheimer's disease with sleep insufficiency: a cross-sectional study on correlations among clinical characteristics, orexin, its receptors, and the blood-brain barrier.Neural Regeneration Research.2023.18(8).1757-1762.SCI |
2. Yin Jiang, Tian-Shuo Yuan, Ying-Chuan Chen, Peng Guo, Teng-Hong Lian, Yu-Ye Liu, Wei Liu, Yu-Tong Bai, Quan Zhang, Wei Zhang*, Jian-Guo Zhang*.Deep brain stimulation of the nucleus basalis of Meynert modulates hippocampal-frontoparietal networks in patients with advanced Alzheimer's disease.Translational Neurodegeneration.2022.11(1).51.SCI |
3. 郭鹏,连腾宏,何明月,张伟娇,罗冬梅,关惠盈,李晶卉,张维佳,张文静,齐婧,岳好,刘湛,郑紫静,张巍*.阿尔茨海默病患者睡眠特征及其与认知障碍的相关性.中国医学前沿杂志(电子版).2022.14(7).1-7.核心期刊 |
4. Jun-Hua Gao , Du-Yu Ding , Yan-Yun Qi , Yu-Ming Huang , Jing-Lin Zhang , Wei Zhang*.Neuropsychological Features in Patients with General Paresis of the Insane at an Early Stage.Medical Science Monitor.2022.28.e938316.SCI |
5. Dan-Ning Li , Teng-Hong Lian , Wei-Jiao Zhang , Ya-Nan Zhang , Peng Guo , Hui-Ying Guan , Jing-Hui Li , Ming-Yue He , Wen-Jing Zhang , Wei-Jia Zhang , Dong-Mei Luo , Xiao-Min Wang , Wei Zhang*.Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms.Frontiers in Aging Neuroscience.2022.14.875059.SCI |
6. Wei-Jiao Zhang , Dan-Ning Li , Teng-Hong Lian , Peng Guo , Ya-Nan Zhang , Jing-Hui Li , Hui-Ying Guan , Ming-Yue He , Wen-Jing Zhang , Wei-Jia Zhang , Dong-Mei Luo , Xiao-Min Wang , Wei Zhang*.Clinical Features and Potential Mechanisms Relating Neuropathological Biomarkers and Blood-Brain Barrier in Patients With Alzheimer's Disease and Hearing Loss.Frontiers in Aging Neuroscience.2022.14.911028.SCI |
7. Lixia Li, Weijia Wang, Tenghong Lian, Peng Guo, Mingyue He, Weijiao Zhang, Jinghui Li, Huiying Guan, Dongmei Luo, Weijia Zhang, Wei Zhang*.The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function and Neuropathological Biomarker in Patients With Alzheimer's Disease.Frontiers in Aging Neuroscience.2022.14.909582.SCI |
8. 姜季委,张巍,陈启东,张贵丽,李汶逸,徐俊*.表现为孤立性皮质病变的抗髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病合并桥本甲状腺炎和干燥综合征一例.中国现代神经疾病杂志.2022.22(09).777-782.核心期刊 |
9. 李晶卉,连腾宏,郭鹏,张巍*.牙周炎与阿尔茨海默病.中国神经免疫学和神经病学杂志.2022.29(04).321-324.核心期刊 |
10. Jun-Hua Gao, Wu-Rong Li, Dong-Mei Xu, Bo-Wen Zheng, Yu-Ming Huang, Wen-Qing Wu and Wei Zhang*.Clinical Manifestations, Fluid Changes and Neuroimaging Alterations in Patients with General Paresis of the Insane.Neuropsychiatric Disease and Treatment.2021.17.69-78.SCI |
11. Xiao-ling Cheng, Li Liu, Li-xia Li, Hui Zhao, Jing-jing Li, Jin-xin Shi, Wei Zhang*.Significance of CHA2DS2-VASC on the severity and hemorrhagic transformation in patients with non-valvular atrial fibrillation-induced acute ischemic stroke. Intern Emerg Med.2021.Epub ahead of print.Epub ahead of print.SCI |
12. .张伟娇,张巍*.尼克酰胺腺嘌呤二核苷酸磷酸氧化酶在血管性认知障碍中的作用及其机制的研究进展。.中华老年医学杂志.2021.40(2).255-259.核心期刊 |
13. Yang Hu, Peng Guo, Teng-Hong Lian, Li-Jun Zuo, Shu-Yang Yu, Li Liu, Zhao Jin, Qiu-Jin Yu, Rui-Dan Wang, Li-Xia Li, Ying-Shan Piao, Wei Zhang*..Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease. Neuropsychiatric Disease and Treatment.Neuropsychiatric Disease and Treatment.2021.17.2041-2051.SCI |
14. 张巍*.阿尔茨海默病与神经免疫炎症.中国医刊.2020.56(1).5-8.核心期刊 |
15. Shu-Yang Yu, Teng-Hong Lian, Peng Guo, Li-Xia Li, Ding-Yu Ding, Dan-Ning Li, Liu Li, Zhao H, Yang Hu, Li-Jun Zuo, Jun-Hua Gao, Qiu-Jin Yu, Zhao Jin, Rui-Dang Wang, Rong-Yang Zhu, Xiao-Ming Wang, Wei Zhang*.Correlations of apathy with clinical symptoms of Alzheimer's disease and olfactory dysfunctions: a cross-sectional study.BMC Neurol.2020.20(1).416.SCI |
16. Shu-Yang Yu, Wan-Lin Zhu, Peng Guo, Shao-Wu Li, Ya-Ou Liu, Teng-Hong Lian, Ding-Yu Ding, Dan-Ning Li, Li-Xia Li, Liu Li, Zhao H, Li-Jun Zuo, Yang Hu, Qiu-Jin Yu, Zhao Jin, Rui-Dang Wang, Jun-Hua Gao, Rong-Yang Zhu, Xiao-Ming Wang, Wei Zhang*.Clinical features and brain structural changes in magnetic resonance imaging in Alzheimer's disease patients with apathy. Aging (Albany NY).2020.12(19).19083-19094.SCI |
17. 李丽霞,连腾宏,郭鹏,丁杜宇,李丹凝,张伟娇,关惠盈,高俊华,张巍*.帕金森病患者伴发体位性低血压的特点及其对认知功能的影响.中华老年医学杂志.2020.39(9).1001-1005.核心期刊 |
18. 刘丽,李丽霞,张铁梅,张巍*.多系统萎缩患者自立性低血压的临床特点及相关因素分析.医学研究杂志.2020.49(2).140-143.核心期刊 |
19. Teng-Hong Lian, Peng Guo, Ya-Nan Zhang, Jing-hui Li, Li-Xia Li, Ding-Yu Ding, Dan-Ning Li, Wei-Jiao Zhang, Hui-Ying Guan, Xiao-Ming Wang, Wei Zhang*.Parkinson's disease with depression: The correlations between neuroinflammatory factors and neurotransmitters in cerebrospinal fluid.Front Aging Neurosci.2020.12. 574776.SCI |
20. 李丽霞,连滕宏,左丽君,郭鹏,扈杨,丁杜宇,李丹凝,刘丽,赵慧,张巍*.血压变异性与帕金森病患者认知功能的关系.中国神经免疫学和神经病学杂志.2020.27(6).448-452.核心期刊 |
21. Teng-Hong Lian,Zhao Jin, Yuan-Zhen Qu, Peng Guo, Hui-Ying Guan, Wei Zhang, Ding-Yu Ding, Dan-Ning Li, Li-Xia Li, Xiao-Ming Wang, Wei Zhang*.The relationships between the retinal nerve fiber layer thickness and clinical symptoms of Alzheimer's disease.Frontiers in Aging Neuroscience.2020.12.584244.SCI |
22. 李婧婧,张巍*.空气污染与认知障碍的关系及其机制的研究进展.中国神经免疫学和神经病学杂志.2020.27(2).151-154.核心期刊 |
23. 李晶卉,张巍*.口腔微生物种群与阿尔茨海默病关系的新进展.阿尔茨海默病及相关病.2020.3(3).204-209.核心期刊 |
24. 程晓玲,刘丽,李婧婧,赵慧,石金鑫,张巍*.老年非瓣膜性心房颤动致心源性脑栓塞后脑出血转化的预测因素分析.中华老年心脑血管病杂志.2020.12.1301-1304.核心期刊 |
25. Peng Guo, Rui-dan Wang, Teng-Hong Lian, Du-yu Ding, Ya-nan Zhang, Wei-Jiao Zhang, Dan-ning Li, Li-xia Li, Jing-hui Li, Hui-ying Guan, Shu-Yang Yu, Li Liu, Yang Hu, Li-jun Zuo, Qiu-jin Yu, Xiao-Ming Wang and Wei Zhang*.Olfactory dysfunction and its association with neuropathologic proteins in cerebrospinal fluid from patients with Parkinson disease.Front. Aging Neurosci.2020.12.594324.SCI |
26. 张伟娇,张巍* .阿尔茨海默病的诊断进展.中国临床保健杂志 .2020.2.148-153.核心期刊 |
27. 郭鹏,左丽君,连腾宏,扈杨,余舒扬,金朝,余秋瑾,刘丽,王瑞丹,李丹凝,朴英善,李丽霞,朱容彦,丁杜宇,高俊华,赵慧,张巍*.帕金森病伴发认知功能障碍患者的临床特点及其与睡眠障碍的关系.神经疾病与精神卫生.2019.第19卷第1期.17-20.核心期刊 |
28. Teng-Hong LIAN#, Peng GUO, Li-Jun ZUO, Yang HU, Shu-Yang YU, Li LIU, Zhao JIN, Qiu-Jin, YU, Rui- Dan WANG, Li-Xia LI, Ying-Shan PIAO, Wei ZHANG*.An investigation on the clinical features and neurochemical changes in Parkinson’s disease with depression. Frontiers in psychiatry.2019.9.723.SCI |
29. 丁杜宇, 张巍*.阿尔茨海默病的神经调控治疗.中国医刊.2019.54(5) .474-477.核心期刊 |
30. 刘丽,李丽霞,赵慧,石金鑫,张巍*.多系统萎缩患者并发尿潴留临床特点及影响因素分析.中国神经免疫学和神经病学.2019.26(5).348-351.核心期刊 |
31. 郭鹏, 张巍*.阿尔茨海默病患者睡眠障碍及其与认知障碍关系的研究.中华老年医学杂志.2019.38(9).173-177.核心期刊 |
32. Teng-Hong LIAN, Wan-Lin Zhu, Shao-Wu Li, Ya-Ou Liu, Peng Guo, Li-Jun Zuo, Yang Hu, Shu-Yang Yu, Li-Xia Li, Zhao Jin, Qiu-Jin, Yu, Rui-Dan Wang, Wei ZHANG*.Clinical features, structural changes, and neuropathological mechanisms of olfactory dysfunction in patients with Alzheimer’s disease.J Alzheimers Dis.2019.70(2).413-423.SCI |
33. Teng-Hong LIAN, Peng GUO, Li-Jun ZUO, Yang HU, Shu-Yang YU, Qiu-Jin, YU, Zhao JIN, Rui-Dan WANG, Li-Xia LI, Wei ZHANG*.Tremor-dominant in Parkinson Disease: the Relevance to Iron Metabolism and Inflammation..Frontiers in neuroscience .2019.13.255.SCI |
34. 刘丽,李丽霞,张铁梅,张巍*.多系统萎缩患者血压昼夜节律变化及夜间高血压相关因素分析.解放军预防医学杂志.2019.37(9).38-39.核心期刊 |
35. 刘丽,程晓玲,李婧婧,张铁梅,杜凤和,张巍*.70 岁及以上老年住院死亡患者疾病特点及临终救治方式分析.中国医刊,2019,54(10):1084-1086.2019.54(10).1084-1086.核心期刊 |
36. Lixia Li, Peng Guo, Duyu Ding, Tenghong Lian, Lijun Zuo, Fenghe Du ,Wei Zhang*.Parkinson’s disease with orthostatic hypotension: analyses of clinical characteristics and influencing factors.Neurological Research.2019.4.1-8.SCI |
37. 郭鹏, 张巍*.帕金森病伴发认知功能障碍患者的临床特点及其与睡眠障碍的关系.神经疾病与精神卫生 .2019.19(1).17-20.核心期刊 |
38. 丁杜宇#,张巍*.阿尔茨海默病与血脑屏障.中华老年医学杂志.2018.98(29).2357-2359.核心期刊 |
39. 郭鹏, 余舒扬, 左丽君, 刘丽, 李丽霞, 朴英善, 扈杨, 连腾宏, 王瑞丹, 余秋瑾, 金朝, 朱荣彦, 张巍*.帕金森病伴发睡眠障碍的临床特点、影响因素及视频多导睡眠图的变化.中国神经免疫学和神经病学杂志.2018.25-1.26-31.核心期刊 |
40. 刘丽,张铁梅,张巍*.冠心病与认知功能障碍的关系.中华心血管病杂志.2018.46(1).74-77.核心期刊 |
41. Shu-yang Yu, Chen-jie Cao, Li-jun Zuo, Ze-jie Chen, Teng-hong Lian, Fang Wang, Yang Hu, Ying-shan Piao, Li-xia Li, Peng Guo, Li Liu, Qiu-jin Yu, Rui-dan Wang, Piu Chan, Sheng-di Chen, Xiao-min Wang and Wei Zhang*.Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study.BMC Neurology.2018.18-9.1-9.SCI |
42. 李丽霞,张巍*.心房颤动与认知障碍的关系和临床表现及治疗.中华老年医学杂志.2018.37-4.377-380.核心期刊 |
43. Qiu-Jin Yu , Shu-Yang Yu , Li-Jun Zuo , Teng-Hong Lian , Yang Hu, Rui-Dan Wang, Ying-Shan Piao, Peng Guo, Li Liu, Zhao Jin , Li-Xia Li , Piu Chan, Sheng-Di Chen, Xiao-Min Wang ,Wei Zhang*.Parkinson disease with constipation: clinical features and relevant factors.Scientific Reports.2018.8.567.SCI |
44. 扈杨, 左丽君, 连腾宏, 余舒扬, 王方, 余秋瑾, 王瑞丹, 张巍*. 帕金森病伴快动眼睡眠行为障碍视频多导睡眠图变化的特点 .中国神经免疫学和神经病学杂志.2018.25(5).316-320.核心期刊 |
45. 郭鹏, 余舒扬, 左丽君, 刘丽, 李丽霞, 朴英善, 扈杨, 连腾宏, 王瑞丹, 余秋瑾, 金朝, 朱荣彦, 张巍*..帕金森病伴发睡眠障碍的临床特点 、相关 因素及视频多导睡眠图的变化.中国神经免疫学和神经病学杂志》.2018.25(1).26-31..核心期刊 |
46. Yu QJ#, Yu SY, Zuo LJ, Lian TH, Hu Y, Wang RD, Piao YS, Guo P, Liu L, Jin Z, Li LX, Chan P, Chen SD, Wang XM, Zhang W*.Parkinson disease with constipation: clinical features and relevant factors. .Scientific Report.2018.8(1).567.SCI |
47. 丁杜宇, 张巍*.阿尔茨海默病与血脑屏障.中华医学杂志。.2018.98(29) .2357-2359.核心期刊 |
48. Qiujin Yu#, Peng Guo, Danning Li, Lijun Zuo, Tenghong Lian, Shuyang Yu; Yang Hu; Li Liu; Zhao Jin; Ruidan Wang, Yingshan Piao, Lixia Li, Xiaomin Wang, Wei Zhang*.Olfactory dysfunction and its relationship with clinical symptoms of Alzheimer disease.. Aging and Disease.2018.9(6).1084-1095.SCI |
49. 李丽霞,张巍*.心房颤动与认知障碍的关系和临床表现及治疗.中华老年医学杂志.2018.37(4).377-380.核心期刊 |
50. Yu SY#, Cao CJ, Zuo LJ, Chen ZJ, Lian TH, Wang F, Hu Y, Piao YS, Li LX, Guo P, Liu L, Yu QJ, Wang RD, Chan P, Chen SD, Wang XM, Zhang W*.Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study. .BMC Neurology.2018.18(1).9.SCI |
51. Zhu B, Li LX, Zhang L, Yang S, Tian Y, Guo SS, Zhang W*, Zhao ZG*. .Correlation of PICALM polymorphism rs3851179 with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review..Metab Brain Dis..2018.;33(6).1849-1857.SCI |
52. Zuo LJ, Guo P, Liu L, Yu SY, Lian TH, Yu QJ, Hu Y, Jin Z, Wang RD, Piao YS, Li LX, Wang YJ, Wang XM, Zhang W*.Analyses of clinical features and investigations on potential mechanisms in patients with Alzheimer’s disease .J Alzheimers Dis..2018.66(2).789-799.SCI |
53. JIN Z, LIAN T-H, ZUO L-J, GUO P,YU S-Y, HU Y, LIU L, YU Q-J, WANG R-D, PIAO Y-S, LI L-X, ZHANG W*.RELATIONSHIP BETWEEN THICKNESS OF RETINAL FIBER LAYER AND CLINICAL SYMPTOMS OF ALZHEIMER’S DISEASE [J].Alzheimer's & Dementia.2018.14 (7, Supplement).428.SCI |
54. 连腾宏, 左丽君, 郭鹏, 扈杨, 余舒扬, 余秋瑾, 王瑞丹, 金朝, 刘丽, 赵慧, 李丽霞, 朴英善, 张巍*.帕金森病伴发抑郁的神经生化机制及白质纤维的变化.中国神经免疫学和神经病学杂志.2018.25(5).311-315.核心期刊 |
55. 王瑞丹, 李丹凝, 左丽君, 郭鹏, 连腾宏, 扈杨, 刘丽, 余舒扬, 陈泽颉, 余秋瑾, 金朝, 赵慧, 李丽霞, 朴英善, 张巍*.帕金森病伴发嗅觉障碍的临床特征及其与非运动症状的关系.《中国神经免疫学和神经病学杂志》.2018.25(5).321-326.核心期刊 |
56. ZHANG W*, GUO P, ZUO L-J, YU S-Y, LIAN T-H, HU Y, LIU L, YU Q-J, JIN Z, WANG R-D, LI L-X, PIAO Y-S.THE CLINICAL CHARACTERISTICS AND RELATED FACTORS OF ALZHEIMER'S DISEASE WITH DEPRESSION [J].Alzheimer's & Dementia.2018.14 (7, Supplement).1491.SCI |
57. ZUO L-J, GUO P, LIU L,YU S-Y, LIAN T-H, YU Q-J, HU Y, JIN Z, WANG R-D, PIAO Y-S, LI L-X, WANGY-J, WANG X-M, ZHANG W*.ANALYSES OF CLINICAL FEATURES AND INVESTIGATIONS ON POTENTIAL MECHANISMS IN PATIENTS WITH ALZHEIMER’S DISEASE AND OLFACTORY DYSFUNCTION [J].Alzheimer's & Dementia.2018.14 (7, Supplement).1489.SCI |
58. 余舒扬, 张铁梅, 张巍*.帕金森病患者嗅觉障碍的横断面观察研究.中国医疗设备.2017.32.65.核心期刊 |
59. 郭鹏, 张巍, 朴英善*.糖代谢异常与阿尔茨海默病.中华老年医学杂志.2017.36.8-11.核心期刊 |
60. Ying-Shan Piao, Teng-Hong Lian, Yang Hu, Li-Jun Zuo, Peng Guo, Shu-Yang Yu, Li Liu, Zhao Jin, Hui Zhao, Li-xia Li, Qiu-jin Yu, Rui-dan Wang, Sheng-Di Chen, Piu Chan, Xiao-Min Wang, Wei Zhang*.Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters.Scientific Reports.2017.7.10547.SCI |
61. Zuo LJ, Piao YS, Li LX, Yu SY, Guo P, Hu Y, Lian TH, Wang RD, Yu QJ, Jin Z1, Wang YJ, Wang XM, Chan P, Chen SD, Wang YJ, Zhang W*.Phenotype of postural instability /gait difficulty in Parkinson disease:relevance to cognitive impairmentand mechanism relating pathological proteins and neurotransmitters.Sci Rep.2017.23:7.44872.SCI |
62. Yang Du, Wenjun Du, Wei zhang, Eng H Lo, Changhong Xing.Differential subnetwork of chemokines/cytokines in human, mouse, and rat brain cells after oxygen-glucose deprivation.Journal of cerebral blood flow and metabolism.2017.37(4).1425-1434.SCI |
63. Li-Jun ZUO, Ying-Shan PIAO, Li-Xia LI, Shu-Yang YU, Peng GUO, Yang HU, Teng-Hong LIAN, Rui-Dan WANG, Qiu-Jin YU, Zhao JIN, Ya-Jie WANG, Xiao-Min WANG, Piu CHAN, Sheng-Di CHEN, Yong-Jun WANG, Wei ZHANG*..Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters..Scientific Reports.2017.7.44872.SCI |
64. 陈泽颉,王瑞丹,张巍*.帕金森病患者嗅觉障碍研究进展.中国神经免疫学和神经病学杂志.2017.24(1).48-52.核心期刊 |
65. 朴英善, 扈杨, 李丽霞, 连腾宏, 余舒扬, 左丽君, 余秋瑾, 王瑞丹, 郭鹏, 金朝, 刘丽, 张巍*.帕金森病伴发不宁腿综合征的临床特征及神经病理生化机制.中国神经免疫学和神经病学杂志.2017.24.7-12.核心期刊 |
66. Liu Z, Shen HC, Lian TH, Mao L, Tang SX, Sun L, Huang XY, Guo P, Cao CJ, Yu SY, Zuo LJ, Wang XM, Chen SD, Chan P, Zhang W*.Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance.Sci Rep.2017.7-1.14973.SCI |
67. 金朝,张巍*.阿尔茨海默病伴发视觉障碍的特点及研究进展.科技导报.2017.35-4.49-53.核心期刊 |
68. Zuo L, Dong Y, Zhu R, Jin Z, Li Z, Wang Y, Zhao X, Sachdev P, Zhang W, Wang Y*. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischemic attack: A validation study.BMJ Open.2017.12-6.e011310.SCI |
69. 赵慧、刘丽、张铁梅*.冠心病与认知障碍.中华老年医学杂志.2016.36(1).14-16.核心期刊 |
70. Wang F, Yu SY, Zuo LJ, Cao CJ, Hu Y, Chen ZJ, Piao YS, Wang YJ, Wang XM, Chen SD, Chan P, Zhang W*.Excessive Iron and α-Synuclein Oligomer in Brain are Relevant to Pure Apathy in Parkinson Disease.J Geriatr Psychiatry Neurol.2016.29(4).187-194 .SCI |
71. 朱荣彦,郭鹏,张巍*.阿尔茨海默病与睡眠障碍.中华老年医学杂志.2016.36(1).1-4.核心期刊 |
72. Zuo LJ, Yu SY, Hu Y, Wang F, Piao YS, Lian TH, Yu QJ, Wang RD, Li LX, Guo P, Du Y, Zhu RY, Jin Z, Wang YJ, Wang XM, Chan P, Chen SD, Wang YJ, Zhang W*.Serotonergic dysfunctions and abnormal iron metabolism: Relevant to mental fatigue of Parkinson disease.Sci Rep.2016.6 (1).19.SCI |
73. Zhang W*, Gao JH, Yan ZF, Huang XY, Guo P, Sun L, Liu Z, Hu Y, Zuo LJ, Yu SY, Cao CJ, Wang XM, Hong JS. Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation.Mol Neurobiol..2016.Epub ahead of print.Epub ahead of print.SCI |
74. Li-Jun ZUO, Shu-Yang YU, Fang WANG, Yang HU, Ying-Shan PIAO, Yang DU , Teng-Hong LIAN, Rui-Dan WANG, Qiu-Jin YU, Ya-Jie WANG, Xiao-Min WANG, Piu CHAN, Sheng-Di CHEN, Yongjun WANG, Wei ZHANG*.Parkinson disease with fatigue: clinical characteristics and potential mechanism relevant to α-Synuclein oligomer..J Clin Neurol.2016.12(2).172-80.SCI |
75. 李丽霞,朴英善,余舒扬,扈杨,左丽君,余秋瑾,王瑞丹,连腾宏,杜阳,张巍*.帕金森病伴发认知障碍患者的营养状况及其影响因素分析.实用老年医学.2016.30(5).588-591.核心期刊 |
76. 左丽君, 扈杨, 余舒扬, 连腾宏, 王方, 朴英善,王瑞丹, 余秋瑾, 郭鹏, 李丽霞,金朝,朱荣彦,杜阳,张巍*.帕金森病不同运动表型与认知障碍关系及其机制的研究.北京医学.2016.38(10).67-72.核心期刊 |
77. 余秋瑾、左丽君、张巍.阿尔茨海默病嗅觉障碍的研究进展.中华老年医学杂志.2016.35(11).1251-1255.核心期刊 |
78. Tie-mei Zhang#,Shu-yang Yu#,Peng Guo, Yang Du, Yang Hu, Ying-shan Piao, Li-jun Zuo, Teng-hong Lian, Rui-dan Wang, Qiu-jin Yu, Zhao Jin, Wei Zhang*.Non-motor symptoms in patients with Parkinson disease: A cross-sectional observational study.Medicine.2016.95(50).e5400..SCI |
79. Wang S, Chu CH, Guo M, Jiang L, Nie H, Zhang W, Wilson B, Yang L, Stewart T, Hong JS, Zhang J..Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.J Neuroinflammation.2016.13(1).158.SCI |
80. 郭鹏 张巍 朴英善*.糖代谢异常与阿尔茨海默病.中华老年医学杂志.2016.36(1).8-11.核心期刊 |
81. 朴英善, 陈泽颉, 左丽君, 余舒扬,扈杨,王方,杜阳,连腾宏,余秋瑾,张巍*.帕金森病伴发不宁腿综合征的临床症状研究.中华老年多器官疾病杂志.2015.14(9).644-649.核心期刊 |
82. Hu Y, Yu SY, Zuo LJ, Cao CJ, Wang F, Chen ZJ, Du Y, Lian TH, Wang YJ, Chan P, Chen SD, Wang XM, Zhang W*..Parkinson disease with REM sleep behavior disorder: Features, α-synuclein, and inflammation..Neurology.2015.84(9).888-894.SCI |
83. 连腾宏, 余舒扬, 左丽君, 朴英善, 扈杨, 王方, 杜阳, 王瑞丹, 余秋瑾,张巍*. 帕金森病伴发抑郁及其相关因素的研究.中华老年多器官疾病杂志 .2015.14(9).650-654.核心期刊 |
84. Yu SY, Zuo LJ,Wang F,Chen ZJ,Hu Y,Wang YJ,Wang XM, Zhang W*.Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study.BMC Neurol.2014.14.113.SCI |
85. Zhang W*,Yan ZF,Gao JH,Sun L,Huang XY,Liu Z,Yu SY,Cao CJ,Zuo LJ,Chen ZJ,Hu Y,Wang F,Hong JS,Wang XM.Role and Mechanism of Microglial Activation inIron-Induced Selective and Progressive Dopaminergic Neurodegeneration. Mol Neurobiol.Mol Neurobiol.2014.49(3).1153-1165.SCI |
86. 左丽君,张巍*.神经免疫炎症与阿尔茨海默病.中华临床医师杂志.2013.7(14).6547-6550.核心期刊 |
87. 孙莉,余舒扬,黄曦妍,刘卓,左丽君,曹辰杰,扈杨,王方,陈泽颉,张巍*.帕金森病伴发认知障碍患者非运动症状特点的研究.中华临床医师杂志.2013.7(11).4799-4805.核心期刊 |
88. Yu SY, Sun L, Liu Z, Huang XY, Zuo LJ, Cao CJ, Zhang W*, Wang XM.Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism.PLoS One.2013.8(12).e82924.SCI |
89. 扈杨,左丽君,余舒扬,曹辰杰,陈泽颉,王方,张巍*.帕金森病患者伴很可能的快速眼动睡眠行为障碍和相关因素的研究.中华临床医师杂志.2013.7(12).5216-5222.核心期刊 |
90. 左丽君,余舒扬,张巍*.阿尔茨海默病的危险因素.中华老年医学杂志.2013.32(9).1021-1024.核心期刊 |
91. 陈泽颉,曹辰杰,余舒扬,左丽君,扈杨,王方, 张巍*.帕金森病伴发幻觉与非运动症状关系的研究.中华临床医师.2013.7(15).6813-6819.核心期刊 |
92. 曹辰杰,余舒扬,左丽君,李辰,扈杨,王方,陈泽颉,张巍*.经颅超声检测帕金森病患者黑质回声的变化与临床症状关系的研究.中华临床医师杂志.2013.7(15).6904-6912.核心期刊 |
93. Zhang W*, Zecca L, Wilson B, Ren HW, Wang YJ, Wang XM, Hong JS.Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death. .Front Biosci.2013. 1(5).1-11.SCI |
94. Wei Zhang*, Li Sun, Shu-yang Yu, Zhuo Liu, Xi-yan Huang, Li-jun Zuo, Chen-jie Cao, Yang Hu, Fang Wang, Ze-jie Chen.Relationships among the cognitive impairment, oligomer alpha-synuclein level and TNF-alpha level in Parkinson’s disease patients with mild cognitive impairment.NEURODEGENER DIS .2013.supplement.online.SCI |
95. Wei Zhang*, Zhuo Liu, Hui-cong Shen, Lei Mao, Shou-xian Tang, Li Sun, Xi-yan Huang, Shu-yang Yu, Chen-jie Cao, Li-jun Zuo,Yang Hu, Fang Wang, Ze-jie Chen.Investigation on the relationship between iron deposit in substantia nigra and the level of IL-1beta in patients with Parkinson’s disease.NEURODEGENER DIS.2013.supplement.online.SCI |
96. 曹辰杰,余舒扬,左丽君,陈泽颉,孙莉,黄曦妍,刘卓,扈杨,王方,张巍*.帕金森病患者伴发自主神经功能障碍与运动症状和非运动症状相关性的研究.中华临床医师杂志.2013.7(15).6898-6903.核心期刊 |
97. 刘卓,孙莉,黄曦妍,曹辰杰,余舒扬,左丽君,张巍*.帕金森病伴发焦虑与运动症状及非运动症状关系的研究.中华临床医师杂志.2012.44(5).354-357.核心期刊 |
98. 黄曦妍,刘卓,张巍*.帕金森病伴发抑郁的研究进展.中国神经精神疾病杂志.2012.38(11).52-55.核心期刊 |
99. 左丽君,余舒扬,曹辰杰,刘卓,黄曦妍,孙莉,扈杨,王方,陈泽颉,张巍*.帕金森病患者疲劳及其相关因素的研究.中华临床医师杂志.2012.6(22).7238-7244.核心期刊 |
100. 孙莉,刘卓,黄曦妍,余舒扬,曹辰杰,左丽君,朴英善,杨雅琴,张巍*.帕金森病轻度认知障碍的特点、相关因素及其对生活质量的影响.中华临床医师杂志.2012.6(10).2634-2639.核心期刊 |
101. 余舒扬,张巍*.帕金森病认知障碍的异质性.中华神经科杂志.2012.45(6).425-428.核心期刊 |
102. 余舒扬,刘卓,孙莉,黄曦妍,曹辰杰,左丽君,朴英善,杨雅琴,张巍*.帕金森病患者睡眠障碍相关因素分析及其对生活质量的影响 .中华临床医师杂志(电子版.2012.6(14).3956-3963.核心期刊 |
103. 刘卓,孙莉,张巍*.铁与帕金森病.中华临床医师杂志.2012.9 (6).5212-5215.核心期刊 |
104. 孙莉,余舒扬,张巍*.帕金森病认知障碍的研究进展.中华临床医师杂志.2012.6(19).52-55.核心期刊 |
105. 刘卓,孙莉,黄曦妍,曹辰杰,余舒扬,左丽君,杨雅琴,朴英善,张巍*.帕金森病伴发焦虑与运动症状及非运动症状关系的研究.中华临床医师杂志.2012.6(2).288-293.核心期刊 |
106. Zhuo Liu, Hui-cong Shen, Lei Mao, Shou-xian Tang, Xi-Yan Huang, Li Sun, Shu-Yang Yu, Chen-Jie Cao, Li-Jun Zuo, Wei Zhang*.Dysfunction of iron homeostasis may contribute to iron deposit in the substantia nigra of patients with Parkinson’s disease.European Journal of Neurology.2012.supplement.online.SCI |
107. Wei Zhang*, Jun-hua Gao, Zhao-fen Yan, Zhuo Liu,Xi-yan Huang, Li Sun, Shu-yang Yu, Chen-Jie Cao, Li-jun Zuo, Jau-shyong Hong, Yong-jun Wang,Xiao-min Wang.Minimally toxic dose of lipopolysacchride and α-Synuclein elicited synergistic dopaminergic neurodegeneration: Role and mechanisms of microglial NOX2.European Journal of Neurology.2012.supplement.online.SCI |
108. 高俊华,闫兆芬,张巍*.小胶质细胞NOX2是神经免疫炎症驱动多巴胺能神经元进行性变性的潜在靶点。.中华神经科杂志.2011.44(6).493-499.核心期刊 |
109. 闫兆芬,高俊华,张巍*.小胶质细胞过度激活与多巴胺能神经元进行性变性的研究进展.中华神经科杂志.2011.44(5).354-357.核心期刊 |
110. Zhang W, Phillips K, Wielgus AR, Liu J, Albertini A, Zucca FA, Faust R, Qian SY, Miller DS, Chignell CF, Wilson B, Jackson-Lewis V, Przedborski S, Joset D, Loike J, Hong JS, Sulzer D, Zecca L*.Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease.Neurotox Res.2011.19(1).63-72.SCI |
111. 高俊华,闫兆芬,刘卓, 孙莉, 黄曦妍,张丽娟, 李博, 张巍* 王晓民.铁选择性损伤多巴胺能神经元的神经免疫炎症机制。.中华神经科杂志.2011.44(6).493-499.核心期刊 |
112. 高俊华,闫兆芬,孙莉,刘卓,黄曦妍,张巍*.帕金森病患者非运动症状的临床研究.中国全科医学.2010.13(8B).2576-2579.核心期刊 |
113. 闫兆芬,高俊华,刘卓,孙莉,黄曦妍,张巍*.同型半胱氨酸在帕金森病患者血浆中的变化及临床意义.中国卒中杂志.2010.5(9).735-740.核心期刊 |
114. 黄曦妍,孙莉,刘卓,闫兆芬,高俊华,张巍*.帕金森病患者抑郁及其相关因素的研究。.中国全科医学.2010.13(10A).3150-3156.核心期刊 |
115. 张巍*,雷征霖,陈海波.血管性帕金森综合征和帕金森病患者血中微量元素的变化.中国卒中杂志.2010.5(01).41-45.核心期刊 |
116. 张巍*.痴呆的治疗及社区关爱.中国全科医学杂志.2009.12(3C).52-53.核心期刊 |
117. 张巍*.小胶质细胞与帕金森病.山东医药.2009.49(20).1-3.核心期刊 |
118. 张巍*,王拥军,Jau-Shyong Hong,王晓民.阿尔茨海默病患者表现帕金森病样临床特征的机制探讨.中国神经免疫学和神经病学杂志.2008.15(5).334-337.核心期刊 |
119. Gao X, Hu X, Qian L, Yang S, Zhang W, Zhang D, Wu X, Fraser A, Wilson B, Flood PM, Block M, Hong JS*.Formyl-methionyl-leucyl-phenylalanine-induced dopaminergic neurotoxicity via microglial activation: a mediator between peripheral infection and neurodegeneration?.Environ Health Perspect.2008.116(5).593-598.SCI |
120. 张巍*,王拥军,Jau-Shyong Hong,王晓民.人神经黑色素导致选择性多巴胺能神经细胞进行性变性.中国神经免疫学和神经病学杂志.2008.15(4).259-262,312.核心期刊 |
121. 张巍*,王拥军,Jau-Shyong Hong,王晓民.人神经黑色素过度激活小胶质细胞:多巴胺能神经细胞进行性变性的新机制.中国神经免疫学和神经病学杂志.2008.15(4).274-278.核心期刊 |
122. Zhang W, Dallas S, Zhang D, Guo JP, Pang H, Wilson B, Miller DS, Chen B, Zhang W, McGeer PL, Hong JS, Zhang J*.Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia.2007.55(11).1178-1188.SCI |
123. Qian L, Xu Z, Zhang W, Wilson B, Hong JS, Flood PM*.Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.J Neuroinflammation.2007.4(1).23.SCI |
124. Pei Z, Pang H, Qian L, Yang S, Wang T, Zhang W, Wu X, Dallas S, Wilson B, Reece JM, Miller DS, Hong JS, Block ML*.MAC1 mediates LPS-induced production of superoxide by microglia: The role of pattern recognition receptors in dopaminergic neurotoxicity.Glia.2007.55(13).1362-1373.SCI |
125. Zhang W, Shin EJ, Wang T, Lee PH, Pang H, Wie MB, Kim WK, Kim SJ, Huang WH, Wang Y, Zhang W, Hong JS, Kim HC*.3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro.FASEB J.2006.20(14).2496-2511.SCI |
126. McLaughlin P, Zhou Y, Ma T, Liu J, Zhang W, Hong JS, Kovacs M, Zhang J*.Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.Glia .2006.53(6).567-582.SCI |
127. Yang S, Yang J, Yang Z, Chen P, Fraser A, Zhang W, Pang H, Gao X, Wilson B, Hong JS, Block ML*.Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress.J Pharmacol Exp Ther.2006.319(2).595-603.SCI |
128. Wang T, Zhang W, Pei Z, Block M, Wilson B, Reece JM, Miller DS, Hong JS*.Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor.FASEB.2006.20 (7).906-915.SCI |
129. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J*.Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.FASEB J.2005.19(6).533-542.SCI |
130. Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Zhang W, Kim HC, Hong JS*.3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.ASEB J .2005.19 (3).395-397.SCI |
131. Qin L, Block ML, Liu Y, Bienstock RJ, Pei Z, Zhang W, Wu X, Wilson B, Burka T, Hong JS*.Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress.FASEB J.2005.19(6).550-557.SCI |
132. Wang T, Pei Z, Zhang W, Liu B, Langenbach R, Lee C, Wilson B, Reece JM, Miller DS, Hong JS*.MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration.FASEB J.2005.19(9).1134-1136.SCI |
133. Wang T, Liu B, Zhang W, Wilson B, Hong JS*.J Pharmacol Exp Ther.J Pharmacol Exp Ther.2004.308(3).975-983.SCI |
134. 张巍*, 雷征霖, 程艳杰,许晶,雷阳,高淑敏,袁宏,李士军,张万琴.血管性帕金森综合征患者抗心磷脂抗体变化及意义.中国临床神经科学杂志.2004.12(1).72 和107.核心期刊 |
135. Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B*.Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.FASEB J.2004.18(3).589-591.SCI |
136. Zhang W, Hong JS, Kim HC, Zhang W, Block ML*.Zhang W, Hong JS, Kim HC, Zhang W, Block ML.Morphinan neuroprotection: new insight into the therapy of neurodegeneration.Crit Rev Neurobiol.2004.16(4).271-302.SCI |
137. 张巍*, 雷征霖, 孙秀兰,宋春莉,许晶,雷阳,高淑敏,董晶琳,张万琴.帕金森病患者事件相关电位的变化及其临床意义.中华神经科杂志.2004.37(1).70.核心期刊 |
138. Liu Y, Qin L, Li G, Zhang W, An L, Liu B, Hong JS*.Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.J Pharmacol Exp Ther.2003.305(1).212-218.SCI |